LeMaitre Vascular, Inc. (LMAT) News

LeMaitre Vascular, Inc. (LMAT): $79.75

0.17 (+0.21%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

B

Filter LMAT News Items

LMAT News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

LMAT News Highlights

  • LMAT's 30 day story count now stands at 4.
  • Over the past 8 days, the trend for LMAT's stories per day has been choppy and unclear. It has oscillated between 1 and 2.

Latest LMAT News From Around the Web

Below are the latest news stories about LEMAITRE VASCULAR INC that investors may wish to consider to help them evaluate LMAT as an investment opportunity.

Insider Sell: Chairman and CEO George Lemaitre Sells 22,288 Shares of LeMaitre Vascular Inc (LMAT)

George Lemaitre, the Chairman and CEO, as well as a 10% Owner of LeMaitre Vascular Inc (NASDAQ:LMAT), has recently sold 22,288 shares of the company's stock.

Yahoo | December 13, 2023

LeMaitre Vascular Inc's CEO George Lemaitre Sells Shares: An Insider Analysis

George Lemaitre, Chairman, CEO, and 10% Owner of LeMaitre Vascular Inc (NASDAQ:LMAT), has recently sold 50,995 shares of the company's stock on December 8, 2023.

Yahoo | December 12, 2023

ESLOY or LMAT: Which Is the Better Value Stock Right Now?

ESLOY vs. LMAT: Which Stock Is the Better Value Option?

Yahoo | December 5, 2023

Sidoti Events, LLC's Virtual December Small-Cap Conference

NEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December ...

Yahoo | December 5, 2023

How Much Upside is Left in LeMaitre (LMAT)? Wall Street Analysts Think 25.24%

The consensus price target hints at a 25.2% upside potential for LeMaitre (LMAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | November 10, 2023

Why You Might Be Interested In LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming Dividend

Readers hoping to buy LeMaitre Vascular, Inc. ( NASDAQ:LMAT ) for its dividend will need to make their move shortly, as...

Yahoo | November 10, 2023

LeMaitre to Participate at Upcoming Investor Conferences in November

BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November. Jefferies London Healthcare ConferenceTuesday, November 14, 2023London, UKJJ Pellegrino, Chief Financial Officer, will present at 11:00 AM GMT Stifel's 2023 Healthcare ConferenceTuesday, November 14, 2023Lotte NY Palace Hotel, New York CityDavid Roberts, President, will present at 1:50 PM ET Piper Sand

Yahoo | November 3, 2023

Are LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Mixed Financials Driving The Negative Sentiment?

With its stock down 18% over the past three months, it is easy to disregard LeMaitre Vascular (NASDAQ:LMAT). We...

Yahoo | November 3, 2023

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2023 Earnings Call Transcript

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2023 Earnings Call Transcript November 1, 2023 LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.34, expectations were $0.31. Operator: Welcome to the LeMaitre Vascular Q3 2023 Financial Results Conference Call. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today’s call is […]

Yahoo | November 2, 2023

Q3 2023 LeMaitre Vascular Inc Earnings Call

Q3 2023 LeMaitre Vascular Inc Earnings Call

Yahoo | November 2, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!